EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Broadly Defined Antibiotic Adjuvants for Pseudomonas aeruginosa

Zhihan Chen iD, Yufan Li iD, Yuanlin Song iD

Canadian Journal of Infectious Diseases and Medical Microbiology · 2026-01 · 2026 (1)

DOI: 10.1155/cjid/1388332 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Canadian Journal of Infectious Diseases and Medical Microbiology, online erschienen am 21.08.2026. Verfasst von Zhihan Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Shanghai Key Laboratory of Lung Inflammation and Injury, Zhongshan Hospital, Shanghai Respiratory Research Institut…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 220 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pseudomonas aeruginosa is a widely distributed opportunistic pathogen with multiple drug resistance, making it particularly challenging to treat in lower respiratory tract infections. Its resistance mechanisms are complex, including low outer‐membrane permeability, efflux pump overexpression, biofilm formation, and quorum sensing (QS) activation. Antibiotic adjuvants, as a strategy to enhance antibiotic efficacy and rapidly mitigate antibiotic resistance, have garnered significant attention. However, the traditional definition of antibiotic adjuvants typically refers to compounds like tazobactam, which lack inherent antibacterial activity but enhance the effects of antibiotics. This narrow definition emphasizes specific strategies to overcome P. aeruginosa resistance while excluding many promising approaches that enhance antibiotic activity through specific or nonspecific mechanisms. In this review, antibiotic adjuvants are defined as compounds coadministered or covalently linked with antibiotics to enhance the activity of the antibiotics. This review summarizes progress in research on “broadly defined antibiotic adjuvants” targeting P. aeruginosa and focuses on the following strategies: (1) enhancing outer‐membrane permeability to facilitate antibiotic entry into the bacterial cell; (2) efflux pump inhibitors (EPIs) to inhibit the bacterial efflux of antibiotics from the periplasm; (3) the “Trojan Horse” strategy, utilizing siderophores or their analogs to deliver antibiotics into bacteria; (4) quorum sensing inhibitors (QSIs), which weaken P. aeruginosa pathogenicity and resistance by blocking QS signaling pathways; and (5) activation of persister cells to enhance the bactericidal effects of antibiotics on persister cells in biofilm, facilitating the elimination of P. aeruginosa in chronic infections. These strategies provide a theoretical foundation for developing novel antibiotic adjuvants, which may contribute to addressing the challenge of P. aeruginosa resistance and improving clinical treatment outcomes.

Schlagwörter

Stichwörter der Autor:innen

Pseudomonas aeruginosaantibiotic adjuvantsantibioticsefflux pump inhibitorsmembrane permeabilizerspersister cellsquorum sensing inhibitorssiderophore analogs

Autor:innen und Institutionen

  • Department of Pulmonary Medicine, Shanghai Key Laboratory of Lung Inflammation and Injury, Zhongshan Hospital, Shanghai Respiratory Research Institute, Fudan University, Shanghai, China, fudan.edu.cn.
  • Shanghai Institute of Infectious Disease and Biosecurity, Shanghai, China.
  • National and Shanghai Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China, fudan.edu.cn.
  • Key Laboratory of Chemical Injury, Emergency and Critical Medicine of Shanghai Municipal Health Commission, Center of Emergency and Critical Medicine, Jinshan Hospital of Fudan University, Shanghai, China, jinshanhos.or…

ORCID-Profile: Zhihan Chen, Yufan Li, Yuanlin Song

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Chen, Z., Li, Y., & Song, Y. (2026). Broadly Defined Antibiotic Adjuvants for Pseudomonas aeruginosa. Canadian Journal of Infectious Diseases and Medical Microbiology, 2026(1). https://doi.org/10.1155/cjid/1388332

Vancouver

Chen Z, Li Y, Song Y. Broadly Defined Antibiotic Adjuvants for Pseudomonas aeruginosa. Canadian Journal of Infectious Diseases and Medical Microbiology. 2026;2026(1). doi:10.1155/cjid/1388332

BibTeX
@article{Chen2026,
  author = {Chen, Zhihan and Li, Yufan and Song, Yuanlin},
  title = {Broadly Defined Antibiotic Adjuvants for Pseudomonas aeruginosa},
  journal = {Canadian Journal of Infectious Diseases and Medical Microbiology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/cjid/1388332}
}
Kostenlos starten →